BlackRock Advisors’s XBiotech XBIT Stock Holding History

BlackRock Advisors’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$67K	Buy	6,622 +693	+12%	+$9.22K	﹤0.01%	3176
2016 Q3	$80K	Hold	5,929	–	–	﹤0.01%	3107
2016 Q2	$124K	Buy	5,929 +4,842	+445%	+$69.9K	﹤0.01%	2856
2016 Q1	$10K	Hold	1,087	–	–	﹤0.01%	3577
2015 Q4	$12K	Sell	1,087 -944	-46%	-$12.1K	﹤0.01%	3600
2015 Q3	$30K	Hold	2,031	–	–	﹤0.01%	3419
2015 Q2	$37K	Buy	+2,031	New	+$42.1K	﹤0.01%	3372

Other funds holding XBIT

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

BlackRock Advisors's XBIT Position: Q4 2016 in Review

BlackRock Advisors increased its XBiotech (XBIT) stake by 12% in Q4 2016, buying an estimated $9.22K and bringing the position to 6,622 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #3176.

BlackRock Advisors first reported a position in XBIT in Q2 2015 and has held it in 7 quarters since. The position peaked at $124K in Q2 2016. 49 funds tracked by Wall St. Rank hold XBIT as of Q4 2016.

BlackRock Advisors held 6,622 shares of XBiotech worth $67K as of Q4 2016.
BlackRock Advisors bought 693 XBiotech shares in Q4 2016, an estimated $9.22K.
XBiotech made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3176 holding.
BlackRock Advisors first reported a position in XBiotech in Q2 2015 and has held it in 7 quarters since.
BlackRock Advisors's XBiotech position peaked at $124K in Q2 2016.
49 funds tracked by Wall St. Rank held XBiotech as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.